Showing 1 posts of 1 posts found.
Novartis’ drug Afinitor has been approved by US authorities as a first line treatment for patients with benign brain tumours …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO